CompoAtlas

GNC WOMEN’S ULTRA MEGA® (Paziņots 2011.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000204/2016
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
Vitatrade, SIA
Manufacturer
General Nutrition Corporation
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
1 tablete dienā
Published pack size
tablete pa 1,6 g
Published packaging
90 tabletes

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
D VITAMĪNSvitamins ; D VITAMĪNS ; 20 ; μgVitamine DVitamin or mineral
A VITAMĪNSvitamins ; A VITAMĪNS ; 750 ; μg REVitamine AVitamin or mineral
C VITAMĪNSvitamins ; C VITAMĪNS ; 150 ; mgVitamine CVitamin or mineral
E VITAMĪNSvitamins ; E VITAMĪNS ; 10 ; mg α-TEVitamine EVitamin or mineral
K VITAMĪNSvitamins ; K VITAMĪNS ; 40 ; μgVitamine KVitamin or mineral
B2 VITAMĪNSvitamins ; B2 VITAMĪNS ; 25 ; mgVitamine B2 (riboflavine)Vitamin or mineral
B1 VITAMĪNSvitamins ; B1 VITAMĪNS ; 25 ; mgVitamine B1 (thiamine)Vitamin or mineral
NIACĪNSvitamins ; NIACĪNS ; 25 ; mg NEVitamine B3 (niacine)Vitamin or mineral
B6 VITAMĪNSvitamins ; B6 VITAMĪNS ; 10 ; mgVitamine B6Vitamin or mineral
FOLSKĀBEvitamins ; FOLSKĀBE ; 200 ; μgFolates (vitamine B9)Vitamin or mineral
BIOTĪNSvitamins ; BIOTĪNS ; 150 ; μgBiotine (vitamine B8)Vitamin or mineral
B12 VITAMĪNSvitamins ; B12 VITAMĪNS ; 10 ; μgVitamine B12Vitamin or mineral
PANTOTĒNSKĀBEvitamins ; PANTOTĒNSKĀBE ; 25 ; mgAcide pantothénique (vitamine B5)Vitamin or mineral
Kalcijsminerals ; Kalcijs ; 250 ; mgCalciumVitamin or mineral
Dzelzsminerals ; Dzelzs ; 9 ; mgFerVitamin or mineral
Jodsminerals ; Jods ; 75 ; μgIodeVitamin or mineral
Magnijsminerals ; Magnijs ; 50 ; mgMagnésiumVitamin or mineral
Cinksminerals ; Cinks ; 7,5 ; mgZincVitamin or mineral
Selēnsminerals ; Selēns ; 100 ; μgSéléniumVitamin or mineral
Varšminerals ; Varš ; 1000 ; μgCuivreVitamin or mineral
Mangānsminerals ; Mangāns ; 1 ; mgManganèseVitamin or mineral
Hromsminerals ; Hroms ; 60 ; μgChromeVitamin or mineral
Molibdēnsminerals ; Molibdēns ; 37,5 ; μgMolybdèneVitamin or mineral
Apelsīnu mizas pulverisplants ; Apelsīnu mizas pulveris ; Citrus × sinensis ; 5 ; mgcitrus sinensisPlant
Acai augļu (ogu) pulverisplants ; Acai augļu (ogu) pulveris ; Euterpe oleracea Mart. ; 5 ; mgeuterpe oleraceaPlant
Dzērveņu ogu pulverisplants ; Dzērveņu ogu pulveris ; Vaccinium macrocarpon ; 7,5 ; mgvaccinium macrocarponPlant
Melleņu ogu pulverisplants ; Melleņu ogu pulveris ; Vaccinium myrtillus L. ; 5 ; mgvaccinium myrtillusPlant
Granātābola sēklu pulverisplants ; Granātābola sēklu pulveris ; Punica granatum L. ; 5 ; mgpunica granatumPlant
Brokoļu pulverisplants ; Brokoļu pulveris ; Brassica oleracea var. italica ; 5 ; mgbrassica oleraceaPlant
Spinātu lapu pulverisplants ; Spinātu lapu pulveris ; Spinacia oleracea L. ; 5 ; mgspinacia oleraceaPlant
Melnā plūškoka ogu pulverisplants ; Melnā plūškoka ogu pulveris ; Sambucus nigra L. ; 5 ; mgsambucus nigraPlant
Vīnogu miziņu pulverisplants ; Vīnogu miziņu pulveris ; Vitis vinifera L. ; 5 ; mgvitis viniferaPlant
Tomātu pulverisplants ; Tomātu pulveris ; Lycopersicon esculentum Mill. ; 5 ; mglycopersicon esculentumPlant
Zaļās tējas lapu pulverisplants ; Zaļās tējas lapu pulveris ; Camellia sinensis (L.) Kuntze ; 25 ; mgcamellia sinensisPlant
HolīnsotherIngredients ; Holīns ; 5 ; mgNot recognisedRole not identified
InozītsotherIngredients ; Inozīts ; 5 ; mgNot recognisedRole not identified
SilīcijsotherIngredients ; Silīcijs ; 2 ; mgNot recognisedRole not identified
BorsotherIngredients ; Bors ; 1 ; mgNot recognisedRole not identified
Titāna dioksīds (E171)otherIngredients ; Titāna dioksīds (E171)Not recognisedRole not identified
LikopēnsotherIngredients ; Likopēns ; 475 ; μgListed as food additive E 160d (EU Union list)Role not identified
LuteīnsotherIngredients ; Luteīns ; 475 ; μgListed as food additive E 161b (EU Union list)Role not identified
ZeaksantīnsotherIngredients ; Zeaksantīns ; 95 ; μgNot recognisedRole not identified
Mikrokristāliskā celuloze (E 460)otherIngredients ; Mikrokristāliskā celuloze (E 460)Listed as food additive E 460(i) (EU Union list)Role not identified
KolagēnsotherIngredients ; Kolagēns ; 12 ; mgNot recognisedRole not identified
HialuronskābeotherIngredients ; Hialuronskābe ; 0,5 ; mgNot recognisedRole not identified
Astaksantīns (no aļģes Haematococcus pluvialis )otherIngredients ; Astaksantīns (no aļģes Haematococcus pluvialis ) ; 25 ; μghaematococcus pluvialisPlant
Alfa-lipoiskābeotherIngredients ; Alfa-lipoiskābe ; 12,5 ; mgNot recognisedRole not identified
Hidroksipropilmetilceluloze (E 464)otherIngredients ; Hidroksipropilmetilceluloze (E 464)Listed as food additive E 464 (EU Union list)Role not identified
Riboflavīns (E 101)otherIngredients ; Riboflavīns (E 101)Vitamine B2 (riboflavine)Vitamin or mineral
Glicerīns (E 422)otherIngredients ; Glicerīns (E 422)Listed as food additive E 422 (EU Union list)Role not identified
Taukskābju magnija sāli (E 470b)otherIngredients ; Taukskābju magnija sāli (E 470b)Listed as food additive E 470b (EU Union list)Role not identified
Silīcija dioksīds (E 551)otherIngredients ; Silīcija dioksīds (E 551)Listed as food additive E 551 (EU Union list)Role not identified
Šķērsšūtās celulozes sveķi (E 468)otherIngredients ; Šķērsšūtās celulozes sveķi (E 468)Listed as food additive E 468 (EU Union list)Role not identified
Nātrija askorbāts (E 301)otherIngredients ; Nātrija askorbāts (E 301)Listed as food additive E 301 (EU Union list)Role not identified
Dl-alfa-tokoferols (E 307)otherIngredients ; Dl-alfa-tokoferols (E 307)Listed as food additive E 307 (EU Union list)Role not identified
Askorbilpalmitāts (E 304(i))otherIngredients ; Askorbilpalmitāts (E 304(i))Listed as food additive E 304 (EU Union list)Role not identified
Želatīns (cūku)otherIngredients ; Želatīns (cūku)Not recognisedRole not identified
Tokoferolu ekstrakts (E 306)otherIngredients ; Tokoferolu ekstrakts (E 306)Listed as food additive E 306 (EU Union list)Role not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Lielbritānija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • D VITAMĪNS
    Read the warning, when it applies and the studies cited

    VITAMIN D (>1,000 - 2,500 IU)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    Sources cited by Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    Sources cited by Health Canada (3)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
    • DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Applies to products containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Contraindications

    Condition of application: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    Sources cited by Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Applies to products containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Known adverse reactions

    Condition of application: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    Sources cited by Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Applies to products providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Health Canada monograph dated 26 June 2026

  • Acai augļu (ogu) pulveris
    Read the warning, when it applies and the studies cited

    ACAI – EUTERPE OLERACEA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (derMarderosian and Beutler 2008).

    Sources cited by Health Canada (1)
    • derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (derMarderosian and Beutler 2008).

    Sources cited by Health Canada (1)
    • derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.

    Health Canada monograph dated 24 April 2026

  • Dzērveņu ogu pulveris
    Read the warning, when it applies and the studies cited

    CRANBERRY - VACCINIUM MACROCARPON

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Sources cited by Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Randomised trial
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Sources cited by Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Case report
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

    DRIED CRANBERRY JUICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Sources cited by Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Randomised trial
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Sources cited by Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Case report
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

  • Melleņu ogu pulveris
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

  • Granātābola sēklu pulveris
    Read the warning, when it applies and the studies cited
  • Melnā plūškoka ogu pulveris
    Read the warning, when it applies and the studies cited

    ELDER – SAMBUCUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).

    Sources cited by Health Canada (1)
    • Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
    • Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Astaksantīns (no aļģes Haematococcus pluvialis )
    Read the warning, when it applies and the studies cited

    Haematococcus pluvialis extract

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Eye strain, Eye fatigue.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 10 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “GNC WOMEN’S ULTRA MEGA® (Paziņots 2011.)”, https://compoatlas.com/en/supplements/latvia/5497-gnc-women-s-ultra-mega-pazinots-2011, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line